You are here: Welcome » Vaccine Innovation Prioritisation Strategy

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
vaccine_innovation_prioritisation_strategy [2022/08/07 00:55]
liam [Personnel] 		vaccine_innovation_prioritisation_strategy [2022/08/07 00:57]
liam [Personnel]
Line 30: Line 30:
 | [[Kelly Moore]]  | [[Vanderbilt University School of Medicine]]  | Adjunct Associate Professor of Health Policy  | | [[Kelly Moore]]  | [[Vanderbilt University School of Medicine]]  | Adjunct Associate Professor of Health Policy  |
 | [[Mark Jit]]  | [[London School of Hygiene and Tropical Medicine]]  | Professor, Vaccine Epidemiology  | | [[Mark Jit]]  | [[London School of Hygiene and Tropical Medicine]]  | Professor, Vaccine Epidemiology  |
 +| [[Mark Papania]]  | [[Centers for Disease Control and Prevention]] (CDC) Global Immunization Division  | Medical Epidemiologist  |
 +| [[Michael Free]]  | Independent  | Independent Consultant; Senior Advisor Emeritus, [[PATH]]  |
Back to top